Close

More on LLY

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+53.1% Growth)
- Ratings (7.3 Score)
- Holders
- Dividends (0.6% Yield)
- Event Driven Deals
- FDA Archive

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (4/30/24)
- M&A (12/31/22 *Est)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

LLY Cash Flow Statement

Click line-items for a historical chart and %
Cash Flows from Operating Activities
Net income
Adjustments to Reconcile Net Income to Cash Flows from Operating Activities:
Depreciation and amortization
Change in deferred income taxes
Stock-based compensation expense
Acquired in-process research and development, net of tax
Net marketing investigation charges paid
Other changes in operating assets and liabilities
Other operating activities, net
Net Cash Provided by Operating Activities
Cash Flows from Investing Activities
Net purchases of property and equipment
Net change in short-term investments
Proceeds from sales and maturities of noncurrent investments
Purchases of noncurrent investments
Purchase of product rights
Cash paid for acquisition
Purchase of in-process research and development
Loan to collaboration partner
Other investing activities, net
Net Cash Used for Investing Activities
Cash Flows from Financing Activities
Dividends paid
Net change in short-term borrowings
Repayment of long-term debt
Other financing activities, net
Net Cash Used in Financing Activities
Effect of exchange rate changes on cash and cash equivalents
Net Increase in Cash and Cash Equivalents
Cash and cash equivalents at January 1
Cash and Cash Equivalents at June 30